Skip to main content

Table 1 Demographic and clinical features of the patients included in the study: CSF samples

From: Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis

  Disease Number of patients Age (Mean ± SD) Gender
Discovery RRMS 69 36.9 ± 10.6 25M; 44F
INF 27 46.4 ± 15.7 10M; 17F
N-INF 42 45.3 ± 11.2 14M; 28F
Validation RRMS 68 36.8 ± 9.9 18M; 50F
INF 53 46.6 ± 15.6 20M; 33F
N-INF 74 51.9 ± 11.9 29M; 45F
  1. M male, F female, RRMS Relapse–remitting multiple sclerosis, INF other inflammatory diseases of the CNS, N-INF non-inflammatory diseases of the CNS